Core Insights - Wall Street analysts expect Agilent Technologies to report quarterly earnings of $1.37 per share, reflecting a year-over-year increase of 4.6% and revenues of $1.8 billion, up 7.2% from the previous year [1] Revenue Estimates by End Markets - Revenue from Chemical and Advanced Materials is projected to reach $413.46 million, indicating a year-over-year increase of 9.1% [4] - Revenue from Environmental and Forensics is expected to be $173.75 million, suggesting a 1% increase year-over-year [4] - Revenue from Diagnostics and Clinical is forecasted at $254.20 million, reflecting a 5.9% increase from the prior year [5] - Revenue from Academia and Government is estimated to be $144.50 million, indicating a 5.5% year-over-year increase [5] - Revenue from Pharmaceuticals is projected at $633.34 million, suggesting an 8.3% increase year-over-year [6] - Revenue from Food is expected to reach $166.52 million, indicating a slight decrease of 0.9% from the previous year [6] Net Revenue Estimates - Net Revenue from the Americas is expected to be $704.33 million, reflecting a year-over-year increase of 5.3% [6] - Net Revenue from Asia Pacific is projected at $604.90 million, indicating a 10.2% increase year-over-year [7] - Net Revenue from Europe is estimated to be $486.16 million, suggesting a 5% increase from the prior year [7] Stock Performance - Agilent's shares have decreased by 8.9% over the past month, compared to a 0.8% decline in the Zacks S&P 500 composite [7] - The company holds a Zacks Rank of 3 (Hold), indicating expectations to mirror overall market performance in the near future [7]

Agilent Technologies, Inc. (A) is a leading provider of instruments, software, services and consumables that support laboratory workflows across life sciences, diagnostics and applied chemical markets worldwide. Agilent is headquartered in Santa Clara, California and has a market cap of $35.8 billion, reflecting its significant presence in the healthcare and research tools sector. The healthcare stock has underperformed the broader market over the past year. Agilent’s stock prices have declined 7.9% over ...

Core Viewpoint - The article highlights various job openings in the scientific instrument industry, emphasizing the qualifications and skills required for each position, which reflects the industry's demand for skilled professionals in sales and technical roles [3][4][6][7][10][12][16][18][20]. Group 1: Job Openings - Agilent is hiring sales engineers nationwide, requiring a master's degree or higher in relevant fields and experience in mass spectrometry [3]. - Haisai is looking for sales engineers with a bachelor's degree or higher, aiming for candidates with at least three years of experience in the scientific instrument industry [4][5]. - Yiyao Technology seeks sales managers in multiple cities, requiring a bachelor's degree in chemistry or related fields and over five years of sales experience [6]. - DCH is searching for regional sales managers with a background in materials science or chemical analysis, needing at least three years of sales experience [7]. - Anton Paar is also hiring sales engineers nationwide, with a preference for candidates with a background in chemistry or related fields [8]. - Fuli Instruments is looking for sales managers in various cities, prioritizing candidates with experience in the instrument industry [10]. - Jenoptik is seeking sales engineers with a strong background in chemical analysis instruments and at least three years of relevant sales experience [12]. - North China Institute of Science and Technology is hiring sales engineers with a focus on mechanical or automation backgrounds [13][14]. - Pano Technology is looking for sales engineers with a background in analytical chemistry or related fields, emphasizing strong communication skills [15]. - Kai Lai is hiring instrument sales engineers with over five years of sales experience in ICP-MS technology [16]. - Lebertech is seeking sales engineers with a chemistry background and at least two years of sales experience in the instrument industry [19]. Group 2: Qualifications and Skills - Most positions require a bachelor's degree or higher in relevant scientific fields, with some roles accepting candidates with a diploma depending on experience [3][4][6][10][18]. - Strong communication, negotiation, and teamwork skills are emphasized across various job descriptions, indicating the importance of interpersonal abilities in sales roles [5][11][12][15]. - Many positions require candidates to have a solid understanding of laboratory instruments and the ability to develop and manage sales channels independently [9][12][14]. - Experience in the scientific instrument industry is a common requirement, with many roles specifying a minimum of three to five years of relevant experience [4][6][7][18][20].

特别提示 微信机制调整，点击顶部"仪器信息网" → 右上方"…" → 设为 ★ 星标，否则很可能无法看到我们 的推送。 张艳丽 鹤壁市产品质量检验检测中心 使 用 气 质 联 用 仪 快 10 年 了 ， 日 常 用 于 农 产 品 中 检 测 农 药 残 留 。 检 测 农 药 残 留 具 有 一 定 的 复 杂 性，一方面，涉及的农药品种繁多，单个样品通常需要检测上百种农药；另一方面，农药残留都 是痕量或超痕量的。为了检得出、检得准，可以说是费尽了心思。 刚开始使用气质联用仪的时候，遇见一系列的问题。为了排查这些问题，从夜不能寐到崩溃。现 在已经用了近 10年了，把这些故障整理了一下，分享给大家。 图 1 ： 气 质 联 用 仪 在使用气质联用仪（ GC-MS）检测农药残留的过程中，常常会遇到一系列故障，例如调谐报告 不通过、进样口压力异常关闭、进样塔无法工作、通讯错误、基线高不出峰、未检测到色谱峰、 色谱峰异常、灵敏度差、样品重复性差以及软件操作故障等。针对这些问题，结合日常实际操作 经验，可以从以下几个方面进行故障排查与仪器的维护保养。 一、 常见故障排除 （一）调谐报告不通过 调谐报告不通过，基本上 ...

Group 1 - The article promotes a subscription service for the Bloomberg Dividend Focus 50, highlighting its focus on dividend stocks [1] - It mentions a live video series called the Underdog Daily Dividend Show, which features potential portfolio candidates [1] - The content encourages audience engagement by inviting comments on stock tickers for future reports [1]

Core Viewpoint - Agilent Technologies Inc. announced a quarterly dividend of 25.5 cents per share, scheduled for payment on April 22, 2026, to shareholders of record as of March 31, 2026 [1] Company Information - Agilent Technologies, Inc. is recognized as a global leader in analytical solutions [1]

Core Viewpoint - Agilent Technologies Inc. has received FDA approval for PD-L1 IHC 22C3 pharmDx as the only FDA-approved companion diagnostic for identifying first-line patients with epithelial ovarian, fallopian tube, or primary peritoneal carcinoma whose tumors express PD-L1 and may be eligible for treatment with KEYTRUDA® [1] Group 1 - The FDA has approved PD-L1 IHC 22C3 pharmDx as a companion diagnostic [1] - This diagnostic is specifically indicated for patients with epithelial ovarian, fallopian tube, or primary peritoneal carcinoma [1] - The approval aids in identifying patients whose tumors express PD-L1 and who may be eligible for KEYTRUDA® treatment [1]

Job Opportunities - Agilent is hiring a Sales Engineer with a Master's degree in relevant fields such as pharmaceuticals, food, environment, chemistry, biology, or materials, and requires strong communication skills and a willingness to learn [3] - Zhiming Future is looking for a Biological Analysis Instrument Sales Consultant in Shanghai, offering a salary range of 8k-13k, requiring a college degree and three years of sales experience in the biological instrument industry [4] - Beiyu Analysis is seeking Sales Representatives in multiple locations, with salary negotiable [5] - Kailai is hiring an Instrument Sales Engineer with a salary range of 15k-25k, requiring over five years of sales experience and familiarity with ICP-MS technology [7] - Tianmei Yituo is looking for a Sales Engineer in Chongqing, offering a salary of 9k-13k, requiring knowledge of various laboratory instruments [8] - Beifen Ruili is hiring a Sales Engineer in multiple cities, with a salary range of 6k-12k, requiring experience in instrument sales [10] - Yena is seeking a Sales Engineer nationwide, requiring over three years of experience in chemical analysis instruments and fluency in English [11] - Ohaus is hiring a Sales Engineer in Beijing and Nanjing, with a salary range of 11k-18k, focusing on laboratory instrument sales [15] - Steel Research Nack is looking for an ICP System Engineer in Beijing, offering a salary of 25k-30k, requiring a Master's degree and extensive experience in ICP spectrometry [26] Skills and Qualifications - Most positions require a Bachelor's degree or higher in relevant fields such as chemistry, biology, or environmental science [6][9][12] - Strong communication skills, customer service awareness, and the ability to work under pressure are commonly sought after [4][6][10] - Experience in sales, particularly in the laboratory or analytical instrument sector, is a significant advantage [7][11][26] - Many roles require the ability to travel frequently and adapt to various work environments [8][9][18]

Core Insights - Active management in short-term bonds has historically delivered returns 25% higher than passive strategies, particularly in the context of geopolitical volatility and inflation concerns in 2026 [1] - The ICE/BAML Global 1-5 Year Investment Grade Index currently yields around 4.33%, suggesting potential annual returns exceeding 5% for actively managed strategies [1] - Active bond ETFs saw record inflows of $56 billion in January, with $27 billion going into active strategies, indicating a significant shift in investor preference towards active management [1] Active Management Advantages - Active managers can achieve superior returns through strategic sector selection and "roll-down" gains as bonds approach maturity [1] - The defensive quality of active management was highlighted in 2025, where the index returned 5.49% despite challenges faced by longer-term bonds [1] - Selectivity in investment is crucial in a volatile market, with active strategies avoiding sectors like auto companies and commercial real estate that are facing rising issues [1] ETF Market Dynamics - The structure of ETFs has evolved into the "default launch vehicle" for new strategies, with active ETF assets increasing from $255 billion in 2020 to $1.3 trillion today [1] - Credit-related bond ETFs attracted $11 billion in January, reflecting a preference for targeted exposure over broad index holdings [1] - If the current pace of active bond ETF inflows continues, total assets could exceed $2 trillion, indicating a long-term shift in investment strategy [1]

Market Overview - The proteomics market was valued at USD 29.92 billion in 2025 and is projected to grow to USD 58.66 billion by 2031, with a CAGR of 11.87% from 2026 to 2031, driven by precision medicine, chronic diseases, and demand for advanced analytical tools [1] - The role of proteomic analysis is expanding in drug discovery, biomarker identification, and disease pathway analysis, enhancing target validation and supporting targeted therapies [2] Regional Analysis - North America leads the proteomics market due to strong investment in biomedical research, advanced laboratory infrastructure, and the presence of major pharmaceutical and biotechnology companies [3] - Europe holds a significant market share, supported by active research programs and a focus on personalized medicine [4] - Asia-Pacific is emerging as a high-growth region, driven by expanding research capabilities and increasing government funding for life sciences [4] Market Trends - There is a growing adoption of proteomics in drug discovery to identify disease biomarkers and improve understanding of therapeutic targets [5] - The integration of proteomics with genomics is enhancing its role in precision medicine, enabling personalized approaches to disease diagnosis and treatment [6] Industry Segmentation - The proteomics market is segmented by components, technologies, and applications, including drug discovery and development [7] - Key technologies include mass spectrometry, chromatography, and next-generation sequencing [8] Competitive Landscape - The proteomics industry consists of established life science technology providers and specialized proteomics solution companies, focusing on expanding analytical capabilities and forming strategic collaborations [9]